Archer-Daniels-Midland Co: Form 10-K for the period ended Dec 31, 2023
Filed with the SEC on Mar 12, 2024 and accepted by EDGAR at Mar 12, 2024, 10:01 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-10-01 to 2023-12-31 | $22.98bn | us-gaap:Revenues |
| Cost of revenue | 12 months2023-01-01 to 2023-12-31 | $86.42bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months2023-10-01 to 2023-12-31 | $1.74bn | us-gaap:GrossProfit |
| Gross profit | 12 months2023-01-01 to 2023-12-31 | $7.51bn | us-gaap:GrossProfit |
| Research and development | 12 months2023-01-01 to 2023-12-31 | $256.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2023-01-01 to 2023-12-31 | $3.46bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 12 months2023-01-01 to 2023-12-31 | $647.0m | us-gaap:InterestExpense |
| Income tax | 12 months2023-01-01 to 2023-12-31 | $828.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-10-01 to 2023-12-31 | $565.0m | us-gaap:NetIncomeLoss |
| Net income | 12 months2023-01-01 to 2023-12-31 | $3.48bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-10-01 to 2023-12-31 | $1.06 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2023-01-01 to 2023-12-31 | $6.43 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-10-01 to 2023-12-31 | $1.07 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2023-01-01 to 2023-12-31 | $6.44 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2023-01-01 to 2023-12-31 | 542,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2023-01-01 to 2023-12-31 | $4.46bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2023-01-01 to 2023-12-31 | $1.49bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2023-01-01 to 2023-12-31 | $977.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 12 months2023-01-01 to 2023-12-31 | $2.67bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-12-31 | $1.37bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-12-31 | $29.77bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-31 | $54.63bn | us-gaap:Assets |
| Current liabilities | At period end2023-12-31 | $18.66bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2023-12-31 | $8.26bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-12-31 | $1.0m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2023-12-31 | $105.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2023-12-31 | $24.14bn | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |
Source: SEC EDGAR, the filing index for accession 0000007084-24-000009. Last ingested by Listed: Oct 24, 2026, 14:51 ET. Listed shows no prices and gives no investment advice.